Melody Becnel

443 total citations
26 papers, 186 citations indexed

About

Melody Becnel is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Melody Becnel has authored 26 papers receiving a total of 186 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 13 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Melody Becnel's work include Multiple Myeloma Research and Treatments (12 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Melody Becnel is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Melody Becnel collaborates with scholars based in United States, Switzerland and Mexico. Melody Becnel's co-authors include Loretta J. Nastoupil, Hans C. Lee, Sattva S. Neelapu, Christopher R. Flowers, Jason M. Johnson, Maria Laura Rubin, Jason R. Westin, Krina K. Patel, Swaminathan P. Iyer and Donna M. Weber and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Melody Becnel

19 papers receiving 184 citations

Peers

Countries citing papers authored by Melody Becnel

Since Specialization

Citations

This map shows the geographic impact of Melody Becnel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melody Becnel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melody Becnel more than expected).

Fields of papers citing papers by Melody Becnel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melody Becnel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melody Becnel. The network helps show where Melody Becnel may publish in the future.

Co-authorship network of co-authors of Melody Becnel

This figure shows the co-authorship network connecting the top 25 collaborators of Melody Becnel. A scholar is included among the top collaborators of Melody Becnel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melody Becnel. Melody Becnel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes and Risk Factors for Influenza and Respiratory Syncytial Virus Lower Respiratory Tract Infections and Mortality in Patients With Lymphoma or Multiple Myeloma: A 7-Year Retrospective Cohort Study 2025 ·Open Forum Infectious Diseases ·Tali Shafat, (unknown), Fareed Khawaja, Ying Jiang, Amy Spallone, Marjorie Vieira Batista, Ella Ariza‐Heredia, Diana Vilar‐Compte, Sairah Ahmed, Melody Becnel, Roy F. Chemaly	0
2	Personalized Neoantigen Peptide Vaccine with or without Lenalidomide for Patients with Intermediate or High Risk Smoldering Multiple Myeloma (SMM) to Prevent Progression to Multiple Myeloma (MM) 2024 ·Blood ·Krina K. Patel, (unknown), Hans C. Lee, (unknown), Sheeba K. Thomas, Donna M. Weber, Melody Becnel, Mahmoud Gaballa, (unknown), Zuzana Berkova, Sattva S. Neelapu, Cara Haymaker, Minghao Dang, Linghua Wang, Gregory Lizée, Robert Z. Orlowski	0
3	Multi-Omic Single-Cell Characterization of Paired and Serial Samples in Responding and Non-Responding Patients Receiving BCMA Bispecific Antibody Therapy for Multiple Myeloma 2024 ·Blood ·(unknown), Hans C. Lee, (unknown), (unknown), Qin Li, Wei Shen Tan, (unknown), (unknown), Oren Pasvolsky, Mahmoud Gaballa, Melody Becnel, (unknown), Krina K. Patel, Pei Lin, Sheeba K. Thomas, Donna M. Weber, Linghua Wang, Robert Z. Orlowski	1
4	Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Penny Fang, Chelsea C. Pinnix, Susan Wu, Hans C. Lee, Krina K. Patel, Neeraj Saini, Melody Becnel, (unknown), Sheeba K. Thomas, Robert Z. Orlowski, Behrang Amini, Pei Lin, Bouthaina S. Dabaja, Jillian R. Gunther	0
5	Safety and Efficacy Outcomes for Patients with High-Risk Multiple Myeloma Receiving Idecabtagene Vicleucel: The MD Anderson Experience 2023 ·Blood ·Oren Pasvolsky, Michelle A.T. Hildebrandt, (unknown), Christopher J. Ferreri, Hans C. Lee, Elisabet E. Manasanch, Sheeba K. Thomas, Donna M. Weber, Mahmoud Gaballa, (unknown), Melody Becnel, Chitra Hosing, Pei Lin, Behrang Amini, Muzaffar H. Qazilbash, Nilesh Kalariya, Robert Z. Orlowski, Krina K. Patel	0
6	Attrition after Referral for Chimeric Antigen Receptor T-Cell (CAR-T) Products in Multiple Myeloma (MM) 2023 ·Blood ·(unknown), (unknown), Oren Pasvolsky, Christopher J. Ferreri, Hans C. Lee, Elisabet E. Manasanch, Sheeba K. Thomas, Donna M. Weber, Mahmoud Gaballa, (unknown), Melody Becnel, Chitra Hosing, Pei Lin, Behrang Amini, Muzaffar H. Qazilbash, Nilesh Kalariya, Misha Hawkins, Sairah Ahmed, Robert Z. Orlowski, Krina K. Patel	0
7	Abstract 775: Integrative genomic and transcriptomic profiling of myeloma precursors in a prospective longitudinal observational study (ORIGIN) 2023 ·Cancer Research ·Minghao Dang, (unknown), Hans C. Lee, Krina K. Patel, Sheeba K. Thomas, Melody Becnel, Donna M. Weber, Pei Lin, Zuzana Berkova, (unknown), (unknown), (unknown), P. Andrew Futreal, Cristhiam Rojas Hernandez, (unknown), Michael H. Kroll, Peter Kühn, Robert Z. Orlowski, Linghua Wang, Elisabet E. Manasanch	1
8	ISAMAR: Multicenter phase II single arm trial of isatuximab (ISA) with/without lenalidomide (LEN) in pts with high risk smoldering multiple myeloma (HRSMM). 2023 ·Journal of Clinical Oncology ·Elisabet E. Manasanch, Neha Korde, Hans C. Lee, Krina K. Patel, Melody Becnel, (unknown), Sheeba K. Thomas, Swaminathan P. Iyer, Sham Mailankody, Behrang Amini, Pei Lin, Zuzana Berkova, Donna M. Weber, (unknown), Sattva S. Neelapu, Sundar Jagannath, (unknown), Robert Z. Orlowski, Ola Landgren	2
9	OA-36 SBCMA predicts progression and is a biomarker of response in myeloma precursor disease followed on prospective studies 2023 ·Clinical Lymphoma Myeloma & Leukemia ·Wei Shen Tan, (unknown), Melody Becnel, Hans C. Lee, Krina K. Patel, (unknown), Mei Huang, Sheeba K. Thomas, (unknown), Zuzana Berkova, Donna Weber, Isere Kuiatse, Neha Korde, Sundar Jagannath, Ola Landgren, Robert Z. Orlowski, Elisabet E. Manasanch	1
10	Initial Results of a Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in Newly Diagnosed and Previously Treated AL Amyloidosis 2022 ·Blood ·Hans C. Lee, Gregory P. Kaufman, Lei Feng, (unknown), Ralph J. Johnson, Donna M. Weber, Sheeba K. Thomas, Qaiser Bashir, Muzaffar H. Qazilbash, Swaminathan P. Iyer, Krina K. Patel, Melody Becnel, Elisabet E. Manasanch, Robert Z. Orlowski	1
11	Retrospective, single-center, real-world experience of belantamab mafodotin in relapsed/refractory multiple myeloma. 2022 ·Journal of Clinical Oncology ·Melody Becnel, Christopher J. Ferreri, Lei Feng, Tiffany Richards, Sandra B. Horowitz, (unknown), Dan S. Gombos, (unknown), (unknown), (unknown), George J. Youssef, Kevin Murphy, Gregory P. Kaufman, Donna M. Weber, Krina K. Patel, Sheeba K. Thomas, Elisabet E. Manasanch, Robert Z. Orlowski, Hans C. Lee	7
12	Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma 2021 ·Haematologica ·Raphaël Steiner, José Banchs, Efstratios Koutroumpakis, Melody Becnel, Cristina Gutiérrez, Paolo Strati, Chelsea C. Pinnix, Lei Feng, Gabriela Rondón, Catherine M. Claussen, Nicolas L. Palaskas, (unknown), Sairah Ahmed, Sattva S. Neelapu, Elizabeth J. Shpall, Michael Wang, Francisco Vega, Jason R. Westin, Loretta J. Nastoupil, Anita Deswal	25
13	Descriptive Analysis of Isatuximab Use Following Prior Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma 2020 ·Blood ·Melody Becnel, Sandra B. Horowitz, Sheeba K. Thomas, Swaminathan P. Iyer, Krina K. Patel, Elisabet E. Manasanch, Donna M. Weber, Gregory P. Kaufman, Hans C. Lee, Robert Z. Orlowski	22
14	The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma 2020 ·Therapeutic Advances in Hematology ·Melody Becnel, Hans C. Lee	16
15	Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma 2019 ·Oral Oncology ·Roberto Carmagnani Pestana, Melody Becnel, Maria Laura Rubin, (unknown), (unknown), Jack Phan, Ehab Y. Hanna, Diana Bell, Bonnie S. Glisson, Jason M. Johnson, J. Jack Lee, Renata Ferrarotto	41
16	Lenalidomide plus rituximab (R²) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial 2019 ·British Journal of Haematology ·Melody Becnel, Loretta J. Nastoupil, Felipe Samaniego, R. Eric Davis, M. James You, Michael R. Green, Fredrick B. Hagemeister, Michelle A. Fanale, Luis Fayad, Jason R. Westin, Michael Wang, Yasuhiro Oki, (unknown), Lei Feng, Sattva S. Neelapu, Nathan Fowler	34
17	Follicular Lymphoma: Past, Present, and Future 2018 ·Current Treatment Options in Oncology ·Melody Becnel, Loretta J. Nastoupil	10
18	Current and future status of stem cell expansion 2018 ·Current Opinion in Hematology ·Melody Becnel, Elizabeth J. Shpall	3
19	Safety and Activity of Lenalidomide and Rituximab in Previously Untreated Marginal Zone Lymphoma: Subgroup Analysis and Long-Term Follow-up of an Open-Label Phase II Trial 2017 ·Blood ·Melody Becnel, Loretta J. Nastoupil, R. Eric Davis, Fredrick B. Hagemeister, Michelle A. Fanale, Luis Fayad, Jason R. Westin, Michael Wang, Yasuhiro Oki, (unknown), (unknown), Lei Feng, Felipe Samaniego, Sattva S. Neelapu, Nathan Fowler	1
20	Disparities in lymphoma on the basis of race, gender, HIV status, and sexual orientation 2017 ·PubMed ·Melody Becnel, Christopher R. Flowers, Loretta J. Nastoupil	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact